)
)
)
Juncell Therapeutics
Juncell is a clinical-stage biotech focused on TIL (tumor-infiltrating lymphocyte) cell therapy for solid tumors. We have improved the safety profile and affordability of TIL therapy without compromising efficacy. We have filed for HKEX IPO.
){kind=logo}
)